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Abstract
Background: Campylobacter fetus subspecies fetus (CFF) is an important pathogen for both cattle and humans.
We performed a systematic epidemiological and clinical study of patients and evaluated the genetic relatedness
of 17 human and 17 bovine CFF isolates by using different genotyping methods. In addition, the serotype, the
dissemination of the genomic island containing a type IV secretion system (T4SS) and resistance determinants for
tetracycline and streptomycin were also evaluated.
Methods: The isolates from patients diagnosed with CFF infection as well as those from faecal samples of healthy
calves were genotyped using pulsed-field gel electrophoresis (PFGE), multilocus sequence typing (MLST), as well as
single locus sequence typing (SLST) targeting cmp1 and cmp2 genes encoding two major outer membrane proteins in
CFF. The presence of the genomic island and identification of serotype was determined by PCRs targeting genes of the
T4SS and the sap locus, respectively. Tetracycline and streptomycin resistance phenotypes were determined by minimal
inhibitory concentration. Clinical data obtained from medical records and laboratory data were supplemented by data
obtained via telephone interviews with the patients and treating physicians.
Results: PFGE analysis defined two major clusters; cluster A containing 16 bovine (80 %) isolates and cluster B containing
13 human (92 %) isolates, suggesting a host preference. Further genotypic analysis using MLST, SLST as well as sap and
T4SS PCR showed the presence of genotypically identical isolates in cattle and humans. The low diversity observed within
the cmp alleles of CFF corroborates the clonal nature of this pathogen. The genomic island containing the tetracycline
and streptomycin resistance determinants was found in 55 % of the isolates in cluster A and correlated with phenotypic
antibiotic resistance.
Conclusions: Most human and bovine isolates were separated on two phylogenetic clusters. However, several human
and bovine isolates were identical by diverse genotyping methods, indicating a possible link between strains from these
two hosts.
Keywords: Campylobacter fetus subspecies fetus, Epidemiology, Multilocus sequence typing (MLST), Pulsed-field gel
electrophoresis (PFGE), Major outer membrane protein (MOMP), Type IV secretion system (T4SS)
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Background
The species Campylobacter fetus is divided into two sub-
species, Campylobacter fetus subspecies fetus (CFF) and
Campylobacter fetus subspecies venerealis (CFV). CFV is
host restricted and is the causative agent of bovine genital
campylobacteriosis. In contrast, CFF is a pathogen affect-
ing animals as well as humans. It has commensal charac-
teristics in a wide range of animals and is most often
associated with abortion in sheep and to a lesser extent in
cattle [1]. In humans, CFF is recognized within other
Campylobacter species as a major causative factor in
extraintestinal illness. It has emerged as a human patho-
gen responsible for serious systemic disease, and although
responding mostly to ampicillin, gentamicin and carba-
penems [2], there is still a documented mortality rate of
up to 14 % [3]. CFF has a predilection for the human vas-
cular endothelium, and the majority of reported infections
include blood stream infections and haematogenous
spread. CFF has been isolated from blood or stool of
humans with endocarditis, mycotic aneurysms, cellulitis,
abscesses, meningitis or meningoencephalitis, vertebral
osteomyelitis, septic arthritis, spontaneous bacterial as
well as continuous ambulatory peritoneal dialysis associ-
ated peritonitis, infectious diarrhea, and more rarely, with
pelvic infection, cholecystitis, pericarditis, pleurisy, pneu-
monia, urinary tract infection and abortion [3–13].
CFF mostly affects immunocompromised patients, elderly
people with an underlying disease and neonates. The
apparently emerging status of CFF might be explained
by the improvement of diagnostic methods, increased
medical awareness and the growing number of immuno-
compromised patients [3, 6–13].
Identification of animal species serving as reservoirs
for human infection and detection of routes of transmis-
sion remain a major public health issue. It is hypothe-
sized that exposure to livestock and raw or undercooked
animal products represent the main sources for human
CFF infections [6]. CFF has been identified in faeces of
beef cattle, sheep, pigs, monkeys, and horses [6, 14, 15].
However, so far no comparative analysis of geno- and
phenotypic data of human and animal CFF strains has
been performed in a given geographic region, and data
from epidemiologic studies of human CFF infection are
still scarce. In the case of CFF, the differentiation of
Campylobacter fetus subspecies has been challenging
[16] with reliable techniques only established recently.
A MLST schema for C. fetus has previously been
reported [14]. A strong correlation was observed be-
tween MLST and PFGE data as well as between MLST
and the two serotypes defined by sapA and sapB. This
study demonstrated the clonal nature of the C. fetus
species and suggested the MLST typing method as the
most appropriate procedure for long-term epidemio-
logical and phylogenetic studies.
In order to increase the discriminatory power and reli-
ably trace the source and route of transmission, further
strain characterization is helpful. Bacterial outer mem-
brane proteins of Gram-negative bacteria are considered
the major mediators of the pathogen-host interaction
and are essential for the microbial adaptation to the host
environment. The porA gene encoding the major outer
membrane protein (MOMP) of C. jejuni and C. coli has
been used to enhance genetic discrimination of isolates
and to identify epidemiologically linked campylobacter
isolates [17]. In C. fetus, the presence of 2 MOMP with
porin activity but different from PorA has been dem-
onstrated, one encoded by cmp1 (GenBank locus tag
CFF8240_0396) and the other by cmp2 (GenBank locus
tag CFF8240_0397), prompting us to include these in
our analysis. Furthermore, T4SS are multicomponent
transporters of Gram-negative bacteria with functions
as diverse as the delivery of effector proteins into
eukaryotic cells in pathogenesis or DNA transfer in
bacterial conjugation [18]. T4SS associated to genomic
islands are crucial for the horizontal transfer of these
genomic islands and might disseminate antibiotic resist-
ance elements [19]. We have recently described the pres-
ence of a genomic island in CFF carrying a T4SS and
two genes conferring resistance to tetracycline and
streptomycin [20].
In this study, we conducted a comprehensive analysis
of a large number of CFF isolates from humans and
animals in order to thoroughly investigate the epidemi-
ology of infection in humans as well as the genetic diver-
sity of bacterial strains and the potential role of cattle as
a reservoir for human CFF infections. Seventeen strains
isolated from humans with CFF infection and 17 strains
from bovine carriers were analyzed by PFGE, MLST,
sap/serotyping and by further genotyping based on
cmp1/cmp2 sequences and PCR detection of T4SS. In
addition, antibiotic resistance towards tetracycline and
streptomycin was determined phenotypically using min-
imal inhibitory concentration (MIC).
Methods
Bacterial isolates
Bacterial CFF isolates from 17 patients were identified
between 2001 and 2009 at our institution, a university
hospital in Switzerland with specialized microbiological
laboratories serving an estimated population of 1.2
million. Confirmation of human CFF infections was
based on positive culture results. C. fetus was identified
by sequencing 500 bp of the 16S rRNA gene. Clinically
relevant patient information was obtained from medical
charts and supplemented by telephone interviews with
patients and treating physicians. Seventeen bovine
isolates originated from faecal samples of healthy calves
from different geographic regions of Switzerland. Bacterial
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strains were cultured on tryptone soya agar containing
sheep blood 5 % v⁄v (Oxoid, Wesel, Germany) under
microaerobic conditions for 2 days at 37 °C. C. fetus subsp.
identification was based on glycine tolerance test. The
results were confirmed by PCR [21].
Geno- and phenotyping, cluster analysis
PFGE was performed using the restriction enzyme SmaI
as previously described [21, 22]. The DNA banding pat-
tern was analyzed using BioNumerics software (version
7.5; Applied Math, Sint-Martens-Latem, Belgium) and a
dendrogram was generated by cluster analysis using a
similarity matrix (settings: Dice, UPGMA with 3 % opti-
misation and 1 % band tolerance). A cut-off at 70 %
similarity of the Dice coefficient was applied to indicate
major PFGE clusters. Fisher’s exact test was used for
statistical analysis of the dendrogram.
The 2 MOMP encoding genes cmp1 and cmp2 in CFF
were partially sequenced. Primers were designed based
on the reference genome sequence of C fetus subsp. fetus
80–40 (GenBank acc. no. NC_008599) to amplify frag-
ments encoding the C-terminal part of these proteins
which contain putative external loop structures, and are
predicted to be the most variable regions in these
proteins. The 3′ part of the gene cmp1 was amplified
with primer pair CFMOMP1_2-L (5′-TTGAAAATGT
TACTGATCTATACGCTATAGAC) and CFMOMP1-R
(5′-AGTTTTATCTTTACCAGCATTGTCTGGCTCTT
CAGTT) resulting in a 536 bp PCR product (position
650–1185 of cmp1). The 3′ part of cmp2 was ampli-
fied with primer pair CFMOMP1_2-L and CFMOM
P2-R (5′-GTTTTTGAAATCGTTTTTGCCATCTATC)
resulting in a 545 bp PCR product (position 641–
1185 of cmp2). Sequence alignments were performed
using the Vector NTI advance software (Invitrogen),
and a unique arbitrary number was given to every
single allele based on the reference sequences of cmp1
and cmp2 of strain 80–40 defining allele number 1
(GenBank locus tag CFF8240_0396 and CFF8240_0397,
respectively). The four allele sequences of cmp1 and the
five of cmp2 have been deposited at GenBank under
accession numbers KU670818-KU670821 and KU670822-
KU670826, respectively. A full matrix including sequences
of all strains analyzed in this study can be accessed at
http://purl.org/phylo/treebase/phylows/study/TB2:S18853.
The MLST analysis was carried out using the protocols
of the C. fetus MLST database as described before
[14]. New alleles and MLST sequence types (ST) were
deposited in the PubMLST database (http://pubmlst.org/
cfetus/). PCR screening for the presence of the T4SS and
susceptibility tests determining MIC for tetracycline and
streptomycin were carried out as previously described
[20]. The analysis of the sap/serotypes was done by
PCR as published [23].
Results
Clinical and epidemiological data of human patients
In humans, diagnosis of CFF infection was based on
positive blood cultures in 76.5 % of cases, and on other
sources in 41.1 % of cases (stool, abscess fluid, biopsies;
in addition to blood cultures in cases 1, 9, 12; Table 1).
CFF was mostly isolated from elderly patients (mean
age, 65 years; range 31–87 years), with a slight prepon-
derance of male patients (10 males, 7 females). The site
of infection was the gastrointestinal tract (colitis) in 6
cases, the native venous tract in 4 cases (deep venous
thrombosis in a leg, in 1 patient (case 11) associated
with erysipelas), the skin (erysipelas) in 2 cases, the
site of foreign material (3 joint prostheses, 1 vascular
Y-prosthesis, 1 implanted central venous catheter
Port-a-Cath®) in 5 cases, and in 1 patient the urinary
tract. Abscess formation was noted in 3 cases: 2 psoas
abscesses associated either with colitis (case 9) or with in-
fection of the hip prosthesis (case 15), and 1 abscess in the
deep tissues of the plantar foot associated with thrombosis
in the leg (case 12). Of the 6 patients with a joint pros-
thesis, only 3 had the infection at the site of the implant.
Seven patients were immunocompromised, confirming
previous observations for susceptibility to CFF infection.
Underlying diseases included most commonly heart
disease (9 patients), arterial hypertension (8 patients),
renal failure (5 patients) and type 2 diabetes mellitus
(4 patients), underscoring the morbidity of this mostly
elderly population. Interestingly, the presence of
diverticulosis (of the sigmoid colon in patients 2, 13
and 15, and of the whole colon in patients 3, 14 and 17)
did not predispose to gastrointestinal infection with
CFF, as only patients 14 and 17 became symptomatic,
whereas colitis was a presenting symptom in patients
1, 4, 6 and 9 who did not have known diverticulosis.
All but patients 10, 11 and 12 were moderately anaemic
(82 %, haemoglobin 90–110 g/L). We found two co-
infections: in patient 1 with Clostridium difficile and in
patient 9 with Campylobacter jejuni (both isolated from
stool specimens). Possible bacterial entry routes were
skin or mucosal lesions in at least 14 out of the 17
patients; for patient 2, this information was not avail-
able. Skin lesions were open wounds including a leg
ulcer (patient 11), whilst mucosal lesions included open
wounds after extraction of a wisdom tooth and removal
of a mandibular cyst (patient 1), oral ulcers (patient 5),
ulcerous cavities due to poor dental status (patient 9),
erosive gastritis (patient 7) and oesophagitis (patient 4).
Most of the patients (59 %) were treated with quino-
lones (ciprofloxacin or ofloxacin), especially when gastro-
intestinal symptoms were present. In the case of colitis,
clarithromycin was successfully used (patients 4 and 14).
In the cases of soft tissue infections (erysipelas, abscess),
either in the presence or absence of venous thrombosis,
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Table 1 Patient data
case Bacterial strain
number
Site of infection,
symptom
Sample(s) for
analysis
Comorbidities Immuno-suppression Skin/mucosa
lesion
Joint
prosthesis
Ingestion of
raw food
Animal
contact
Therapy Outcome
1 H_900686 colitis blood, stool KT, HT, RF yes (pt) yes (enoral) no v dogs Q recovery
2 H_914559 UTI blood KT, HD, Div, RF yes (pt) u hip v, e cats Q recovery
3 H_932845 erysipelas blood HD, HT, DM,
Div, W
yes (st, cy) no no u u P recovery
4 H_1029625 colitis, VT blood AIDS, HD,
COPD
yes (AIDS) yes (esophageal) no rm, e no Cla recovery
5 H_1103393 elbow joint
prosthesis
biopsy gt elbow
joint
RA yes (chloroquine) yes (elbow, enoral) elbow rm dogs,
horses
P; Q, R relapse 2
years later
6 H_1277769 colitis blood LT, PV, RF, HT yes (pt) no no v no Q recovery
7 H_1113346 Port-a-Cath blood NHL yes (chemotherapy) yes (skin, erosive gastritis) no v, e dogs Q recovery
8 H_1084325 VT blood HD, anemia no yes (skin) no no no P recovery
9 H_1136201 colitis, psoas
abscess
abscess, blood HD, COPD, HT,
Dem, AlcAb
no yes (mucosa) hip rm, e, g no Q recovery
10 H_1223747 hip joint prosthesis biopsy gt hip joint;
stool
- no yes (esophageal) hip v, rm cats, dogs Q, R; Cla; Q chronic
infection
11 H_1289205 VT, erysipelas blood HD, DM no yes (skin) no v c, dogs,
poultry
P; C recovery
12 H_1437517 VT, abscess foot biopsy gt and
abscess, foot, blood
HT, portacath no yes (skin) hip, knees v c, cats, p,
dogs
P; C; Q recovery
13 H_1456372 vascular Y-prosthesis blood HT, HD, RF,
DM, Div
no yes (mucosa) no v, e, g p C; Do recovery
14 H_1473712 colitis stool HT, HD, Div,
DM, COPD
no yes (mucosa) no rm no Cla recovery
15 H_1516477 hip joint prosthesis,
psoas abscess
abscess fluid; biopsy
gt hip
Div no yes (mucosa) hip v s, cats Q; P recovery
16 H_1539713 erysipelas blood HT, HD, RF, PD no yes (skin) no v no P recovery
17 H_1599086 colitis blood Div, COPD, AlcAb no yes (mucosa) no v bi, tu, fi Q recovery
AIDS acquired immunodeficiency syndrome, AlcAb alcohol abuse, COPD chronic obstructive pulmonary disease, Dem dementia, Div diverticulosis, DM diabetes mellitus type 2, HD heart disease, HT hypertension,
KT kidney transplant, LT liver transplant, PD Parkinson’s Disease, PV polycythemia vera, RA rheumatoid arthritis, RF renal failure, UTI urogenital tract infection, VT venous thrombosis, W Wegener granulomatosis,
gt granulomatous tissue, cy cyclophosphamid, pt post-transplant, st steroids, e raw eggs, rm raw meat, u unknown, v vegetables, bi birds, c cattle, fi fish, g goat cheese, gp guinea pigs, p pigs, s sheep, tu turtles,
C carbapenem, Cla clarithromycin, Do doxycycline, P amoxicillin/clavulanic acid, Q quinolone, R rifampicin
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amoxicillin was more readily used. The use of antibiotics
was always adapted to the susceptibility results of the
isolates. In the patients with prosthetic device infection
(joints and catheter), only complete removal of the
synthetic material and concomitant, longstanding anti-
biotic therapy led to the resolution of the infection. For
example in patient 15, symptomatic CFF infection re-
curred 6 years after the first CFF infection and antibiotic
therapy; the patient was finally cured after removal of
the osteosynthetic material. In patients 5 and 10, antibiotic
therapy alone over years (2 and 3 years, respectively)
led to control of the chronic infection and formation
of a fistula.
At the time of CFF bacteremia, patient 13 had a PET/
CT scan showing 18F-FDG uptake at the site of the
aortoiliac Y-prosthesis, suggesting infection of the pros-
thesis which was implanted 2 years before. Antibiotic ther-
apy alone (meropenem followed by oral doxycycline for
3 months) led to resolution of the inflammatory signs in
the blood and negative blood cultures on follow-up. None
of the 17 patients died due to CFF infection.
Epidemiological data reveal contact with animals for
59 % of the patients. However only a minority had con-
tact with animals known to be carriers of CFF: horses
(patient 5), cattle (patient 11 and 12), pigs (patients 12
and 13), sheep (patient 15) and turtles (patient 17). All
but one subject (patient 8) either consumed raw or
undercooked meat (patients 4, 5, 9, 10, 14), raw eggs
(patients 2, 4, 7, 9, 13) and/or raw vegetables (patients 1,
2, 6, 7, 10, 11, 12, 13, 15, 16, 17). Patient 13 was a
butcher, and patients 1, 2, 3, 5, 8, 9, 10, 11, 12, 13, 15,
and 16 (71 %) were regularly visiting farms or were
working there (patients 11, 12 and 15 were farmers).
One patient (case 6) frequented a swimming pool, and
only 2 patients (cases 10 and 15) had contact with young
children. Traveling was limited: 9 patients never traveled,
5 patients visited other small localities within Switzerland
occasionally, and 3 patients had been to Southern
Germany, Spain, or South Africa in the last 3 years.
Comparative genotypic and phenotypic analyses between
human and bovine isolates
PFGE, MLST and sap/serotyping
PFGE analysis grouped the human and bovine CFF iso-
lates into two major clusters A and B (Fig. 1). These two
main clusters showed a Dice similarity coefficient higher
than 70 %. In agreement with previous observations [14],
there was a 100 % correlation between results of PFGE
and MLST analyses. Cluster A contained 17 isolates of the
MLST sequence type (ST) ST-2, 2 isolates of ST-5, and 1
isolate of ST-34. Cluster B contained 8 isolates ST-6, 4 iso-
lates ST-3, and 2 isolates ST-35. There was no overlap of
ST between the clusters.
Serotyping by PCR gave a specific band with all iso-
lates, either for sapA or for sapB but never for both. The
two serotypes were found in both clusters and in human
as well as bovine isolates. There was an association of
serotypes with subclusters in cluster A and B determined
by PFGE as well as MLST (Fig. 1).
Cluster A contained 4 human and 16 bovine isolates,
and cluster B 13 human and 1 bovine isolate. Within
cluster A, of the 4 isolates originating from human sam-
ples, 1 and 2 isolates were sharing a 100 % homology of
the analyzed characteristics with 2 and 3 isolates from
cattle, respectively (human isolate H_1029625 with cattle
isolates IMD_1305/06 and IMD_1585/06; human iso-
lates H_1539713 and H_1473712 with cattle isolates
IMD_950/06, IMD_2221/06 and IMD_523/06). Within
cluster B, the only strain isolated from cattle shared
characteristics with 2 strains isolated from humans (cat-
tle isolate IMD_2365/06 and human isolates H_1103393
and H_1277769). Overall, a striking separation of strains
from bovine and human origins into clusters A and B,
respectively, was observed, indicating an association
between strain and origin of isolates (p < 0.0001). Despite
this fact, identical strains between human and bovine
samples were identified in each cluster.
cmp1 and cmp2 analyses
The locus tags CFF8240_0396, and CFF8240_0397 of the
CFF strain 82–40 (GenBank acc. No: NC_008599) were
used as a reference for cmp1 and cmp2, respectively. The
nucleotide diversity of the 3′ part of both cmp genes was
analyzed in all the isolates, and arbitrary numbers setting
the reference sequence as 1 were used to distinguish the
allele sequences (Table 2). Fifteen and 22 variable nucleo-
tide positions were identified in cmp1 and cmp2, respect-
ively. Silent substitutions are indicated in lower cases,
non-silent ones in upper cases. They were calculated using
the in frame predicted amino acid sequences of both
genes. Interestingly, some of the nucleotide substitutions
are shared between both, equally long cmp gene se-
quences, indicating most likely a gene duplication event
and/or the same purifying selection. The allele type of
both genes correlated highly with the clusters obtained by
PFGE and MLST, and a similar level of discrimination was
observed as for the PFGE and MLST analyses (Fig. 1).
Moreover, cmp gene sequence types demonstrate a 100 %
discrimination between cluster A and B. With cmp1 only
type 2 was found in cluster A, i.e. in the human as well as
the bovine isolates. In cluster B, only cmp1 sequence types
1, 3, and 4 were found. Type 3 was found in the bovine as
well as in human isolates. With respect to cmp2, sequence
types 2 and 5 were only found in cluster A, with 2 found
in both, human and bovine, while 5 only in bovine iso-
lates. Types 1, 3 and 4 were only detected in cluster B with
type 3 in isolates from both hosts.
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Additionally, the predicted amino acid sequences
encoded by cmp1 and cmp2 of the reference CFF strain
82–40 were further analyzed. Using the TMB-Hunt pro-
gram (http://www.bioinformatics.leeds.ac.uk/), we classi-
fied both proteins as transmembrane beta barrel
proteins using whole sequence amino acid composition
[24]. Therefore, the topology of the outer membrane
proteins with respect to lipid bilayer was predicted with
the PRED-TMBB web server (http://biophysics.biol.
uoa.gr/PRED-TMBB/). In the cmp1 encoded protein, 16
transmembrane domains and 8 external loops were
identified, whereas in the cmp2 encoded protein 20
transmembrane domains and 10 external loops were
found. In both, none of the predicted amino substi-
tutions affected the predicted topology of the
proteins.
T4SS and resistance to tetracycline and streptomycin
The T4SS was identified in 11 isolates of cluster A
(55 %) and in 1 isolate of cluster B (7 %), in bovine as
well as in human samples. There was an expected and
complete concordance of the presence of T4SS and re-
sistance to tetracycline and streptomycin, as indicated by
higher MIC values. These results suggest that CFF
strains with the T4SS all carry a transferable pathogen-
icity island. Complete genetic analysis and demonstra-
tion of the presence of the antibiotic resistance genes
tet(44) and ant(6)-Ib has been shown elsewhere in detail
for the bovine clone IMD_523/06 [20].
Discussion
Human infections with CFF are generally sporadic [6, 25].
Extensive clinical and epidemiological data from our
Fig. 1 Cluster analysis of all human and bovine strains. A dendrogram was generated using a similarity matrix (settings: Dice, UPGMA with 3 %
optimisation and 1 % band tolerance) from the results of pulse-field gel electrophoresis using the restriction enzyme SmaI and DNA banding ana-
lysis using BioNumerics software. Cluster analysis was completed with the genotypic and phenotypic characteristics of the strains: multilocus se-
quence typing (ST), sap/serotype, allele derived from gene sequences for major outer membrane proteins cmp1 and cmp2, presence (+) or
absence (−) of a genomic island containing type IV secretions system (T4SS) and resistance (expressed as minimal inhibitory concentration, MIC)
to the antibiotics tetracycline (MIC Tet) and streptomycin (MIC Strep). With a cut-off at 70 % of similarity of the Dice coefficient, 2 major clusters A
and B are identifiable
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patients infected with CFF show that infection predom-
inantly occurs in the 6th decade and manifests itself
mostly as colitis, phlebitis /thrombosis, or infection at
sites of foreign bodies such as osteosynthetic or vascular
prosthetic material. The patients in this study principally
live in the countryside, have regular contacts with farm
animals including cattle, horses and pigs, and are con-
sumers of raw meat or raw vegetables. The patients were
successfully treated with amoxicillin/clavulanic acid,
quinolones, clarithromycin or carbapenems according to
susceptibility testing; in the cases of joint prosthesis,
only removal of the prosthesis led to cure. No death
due to CFF infection occurred in our study.
Our demographic data regarding age at infection
(65 % ≥60 years) and source of isolation (blood in 65 %)
are in concordance with data from a large survey in
Canada reporting age ≥70 years in 53 % and blood as
site of infection in 69 % of the cases [13], from France
(mean age 69.5 years) [9], or Taiwan (mean age
60.5 years) [11]. It has been suggested that CFF is the
most common species causing bloodstream infection
among Campylobacter species (53 %) [3], and that, as in
the present study, patients with CFF infection are more
often male [3, 6–12]. Additionally, our data show a lar-
ger number of comorbidities and no clear association
with liver disease or cirrhosis (only 2 patients with alco-
hol abuse) [6–12]. Our results confirm the frequent
finding of soft tissue infection or thrombosis/thrombo-
phlebitis [6, 9, 10], but, in contrast to one study, colitis
was frequent as well [10]. In addition, at variance with
previous case reports, we found no infection associated
with dialysis procedures [26–28], no infection of the
central nervous system [29] or the spine [30–32], no
pleural or pulmonary infection [33–35] and no endo-
carditis [29, 36–39], despite patient 16 carrying an
implanted pacemaker (endocarditis was ruled out by
repeated transoesophageal echocardiography). Within
our study, there were 3 cases of deep muscle abscesses
(patients 9 and 15 with psoas abscess, patient 12 with
abscess in deep soft tissue of the foot involving the mus-
cles), yet deep muscle abscesses have not been reported
previously in the literature. This difference may be due
to the low frequency of the infection in the population,
the low numbers of patients in the studies, or the
physician’s lack of awareness in looking for this infec-
tion. A minority of patients in our study were
immunosuppressed or immunocompromised, and im-
pairment of the immunological response might favour
the occurrence of CFF infection, as does diabetes
mellitus and alcohol abuse. Furthermore CFF has a
predilection for spreading to sites of implanted medical
devices [3, 6, 7, 9, 11]. In contrast to one published report,
antibiotic therapy alone failed to eradicate CFF of joint
prosthesis infections in our cases. Whether the antibiotic
regime applied in the mentioned study (3 weeks of
intravenous ceftriaxone followed by a macrolide) was
causally responsible for the therapeutic success re-
mains to be established in further cases [40].
Due to the low level of genetic diversity even found in
host and geographically unrelated strains, C. fetus is con-
sidered as a species with a clonal nature [14]. In order to
obtain a higher discrimination and to investigate a host
preference of CFF isolates, we additionally performed
single locus sequence typing (SLST) with the loci of two
major outer membrane proteins encoded by cmp1 and
cmp2. Low diversity was found, pointing to a conserved
basic function of these proteins, or to a low level of
adaptive pressure. T4SS genomic islands were found in
the groups with the ST-2 and ST-6 sequences only; how-
ever, within those groups not in all strains. As there is
no correlation between genotypes and the T4SS analysis,
T4SS genomic islands seem to spread across strains in a
Table 2 Variable nucleotide positions identified within the 3′ part of cmp1 and cmp2 of CFF
Gene/Allelea Nucleotide substitutions and position within the gene
cmp1 688 696 697 712 715 716 720 723 726 729 732 738 740 741 825 960
1 G T G T A A T A G C A C C T C C
2 - c A c G C - t a t t t G C - -
3 A - - - - - - - - - - - - - t -
4 A - - - - - - - - - - - - - t t
cmp2 679 687 688 703 706 707 714 717 720 723 729 731 732 740 761 765 771 774 775 776 912 1107
1 G T G T A A A G C A C C T G A C T T T T C C
2 - c A c G C t a t t t G C - - - - - - - - -
3 A - - - - - - - - - - - - - - - - - - - t -
4 A - - - - - - - - - - - - - G t c c G C - -
5 A - - - - - - - - - - - - A - - - - - - - t
aThe corresponding allele numbers were arbitrarily chosen with the reference sequences for cmp1 and cmp2 of C. fetus subsp. fetus strain 82–40 (GenBank acc.
No. NC_008599) defined as allele number 1. The hyphen indicates an identical nucelotide as in the reference sequence (allele 1 in bold). Nucleotides in lower case
indicate silent mutations
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strain-independent manner. When human and bovine
isolates were compared, cluster analysis predominantly
segregated them into 2 distinct clusters. The level of
association between clusters and origin of the isolates
was statistically highly significant (p < 0.0001), indicating
a host preference, with tropism a well known feature of
Campylobacter fetus subspecies [41]. Within the human
samples no clear association was found between the
PFGE, MLST or cmp types and the clinical findings of
the patients.
More striking, however, was the sharing of identical
genotypic and phenotypic characteristics within the
clusters between strains originating from human and
cattle. Despite a host-specific separation in two clus-
ters, the fact that 5 human strains from both clusters
were identical to bovine isolates is a strong indication
of a possible link between the two hosts. Moreover,
the ST-6 found in our study only in human isolates
was found in other animal sources as well, mainly
cattle [14]. When comparing our data with MLST
data of that study based on 140 CFF isolates from di-
verse geographic backgrounds and host species, we
found only a limited number of MLST and cmp types,
possibly reflecting the circumscribed geographic re-
gion in our study. Closer analysis of the mentioned
study [14] shows that, in agreement with our findings,
there is a larger homology between human and ani-
mal strains within the same geographical region than
across the globe: for example, the same CFF clone
was found in human as well as in bovine samples
from Great Britain (C036959 and BT 10/98, respect-
ively). The finding of identical strains, as analyzed by
extensive genetic and phenotypic tests, suggests that
the same CFF clone can affect both humans and cat-
tle. The fact that only a few strains were found in
both human and cattle might indicate animal species
not included in this study as sources of infection.
Infection by ingesting raw food has been hypothesized
previously [6, 27, 29, 42–45]. In the present study, fifteen
out of 17 patients (88 %) had regularly ingested raw food
in their diet, with 65 % consuming raw vegetables on a
regular basis. Furthermore, 53 % reported a combination
of raw food ingestion and the presence of oral ulcers,
including wounds due to tooth extraction procedures in
patient 1. This latter coincidence has been reported pre-
viously [38]. Overall, 82 % reported the presence of skin
or mucosal lesions at the time of infection. Whether
these observations are pointing to a possible route of in-
fection, as suggested previously [46], remains to be
shown.
Conclusions
Genotypes of CFF showed a certain host association by
forming two clusters of mainly human or predominantly
bovine isolates. However, the presence of identical
strains in humans and cattle may indicate a possible link
between strains from these two hosts. Studies with other
sources could be addressed in the future.
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